DE68917071T2 - Mittel zur stimulierung der tränensekretion. - Google Patents

Mittel zur stimulierung der tränensekretion.

Info

Publication number
DE68917071T2
DE68917071T2 DE68917071T DE68917071T DE68917071T2 DE 68917071 T2 DE68917071 T2 DE 68917071T2 DE 68917071 T DE68917071 T DE 68917071T DE 68917071 T DE68917071 T DE 68917071T DE 68917071 T2 DE68917071 T2 DE 68917071T2
Authority
DE
Germany
Prior art keywords
stimulating
agent
tear secretion
tear
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE68917071T
Other languages
English (en)
Other versions
DE68917071D1 (de
Inventor
Ronald Schoenwald
Charles Barfknecht
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Iowa Research Foundation UIRF
Original Assignee
University of Iowa Research Foundation UIRF
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Iowa Research Foundation UIRF filed Critical University of Iowa Research Foundation UIRF
Application granted granted Critical
Publication of DE68917071D1 publication Critical patent/DE68917071D1/de
Publication of DE68917071T2 publication Critical patent/DE68917071T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE68917071T 1988-03-16 1989-03-13 Mittel zur stimulierung der tränensekretion. Expired - Fee Related DE68917071T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/168,680 US4820737A (en) 1987-02-17 1988-03-16 Lacrimal secretion stimulant (lss)
PCT/US1989/001001 WO1989008452A1 (en) 1988-03-16 1989-03-13 Lacrimal secretion stimulant (lss)

Publications (2)

Publication Number Publication Date
DE68917071D1 DE68917071D1 (de) 1994-09-01
DE68917071T2 true DE68917071T2 (de) 1994-12-01

Family

ID=22612490

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68917071T Expired - Fee Related DE68917071T2 (de) 1988-03-16 1989-03-13 Mittel zur stimulierung der tränensekretion.

Country Status (9)

Country Link
US (1) US4820737A (de)
EP (1) EP0363469B1 (de)
JP (1) JP2929384B2 (de)
KR (1) KR0135634B1 (de)
AT (1) ATE109001T1 (de)
AU (2) AU611021B2 (de)
CA (1) CA1328665C (de)
DE (1) DE68917071T2 (de)
WO (1) WO1989008452A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256698A (en) * 1987-02-17 1993-10-26 University Of Iowa Research Foundation Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine derivatives
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
AU1747992A (en) * 1991-03-29 1992-11-02 University Of Iowa Research Foundation, The Ophthalmic uses of sigma site binders
US5225424A (en) * 1992-10-21 1993-07-06 University Of Iowa Research Foundation Methazolamide-derived carbonic anhydrase inhibitors
WO1994016685A1 (en) * 1993-01-28 1994-08-04 University Of Iowa Research Foundation Ophthalmic uses of signa agonists
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5322859A (en) * 1993-02-08 1994-06-21 University Of Iowa Research Foundation Antiglaucoma drug composition and method
US5387614A (en) * 1993-07-27 1995-02-07 University Of Iowa Research Foundation Use of sigma receptor ligands as salivary gland stimulants
US5961987A (en) * 1996-10-31 1999-10-05 University Of Iowa Research Foundation Ocular protein stimulants
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
US8143254B2 (en) * 2005-02-18 2012-03-27 Cornell Research Foundation, Inc. Methods for modulating ion channels
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289787A (en) * 1977-12-19 1981-09-15 Eli Lilly And Company Quaternary ammonium antiarrhythmic drugs
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage

Also Published As

Publication number Publication date
EP0363469A4 (en) 1991-05-15
EP0363469B1 (de) 1994-07-27
WO1989008452A1 (en) 1989-09-21
JP2929384B2 (ja) 1999-08-03
AU3414289A (en) 1989-10-05
EP0363469A1 (de) 1990-04-18
JPH02503442A (ja) 1990-10-18
US4820737A (en) 1989-04-11
KR900700091A (ko) 1990-08-11
CA1328665C (en) 1994-04-19
AU8351491A (en) 1991-11-14
KR0135634B1 (ko) 1998-04-23
ATE109001T1 (de) 1994-08-15
DE68917071D1 (de) 1994-09-01
AU611021B2 (en) 1991-05-30

Similar Documents

Publication Publication Date Title
DE68917071T2 (de) Mittel zur stimulierung der tränensekretion.
ES2180530T3 (es) Sulfonamidas de tiofeno utiles como inhibidores de anhidrasa carbonica.
DE1300150T1 (de) Prostaglandin-Derivate zur Behandlung von Glaukom oder Augenüberdruck
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
SE7903186L (sv) Cerebralverksamt medel
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
FR2358157A1 (fr) Oligosaccharides sulfates utiles notamment comme inhibiteurs du complement
ES2110414T3 (es) Derivados de sacarina utiles como inhibidores de enzimas proteoliticas y su preparacion.
CA2070685A1 (en) Method for treating painful, inflammatory or allergic disorders
DE3788231T2 (de) Kosmetisches mittel und zusammensetzung zur behandlung der haut.
DE69113221T2 (de) Antiatherosclerotische und antithrombotische 2-amino-6-phenyl-4h-pyran-4-one.
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
EP0992243A4 (de) Stoff für die prophylaxe oder therapie
NO984160L (no) FremgangsmÕte for behandling eller forebyggelse av interstitiell cystitt
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
DE3875349D1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
ES2083636T3 (es) Componente adhesivo para la restauracion de la sustancia dental dura.
ES2014494B3 (es) Procedimiento para el tratamiento de material de fibra de celulosa coloreada
SE7708176L (sv) Bensamidforeningar
DE3866653D1 (de) Zusammensetzung fuer die behandlung der epidermis.
DK277387A (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
NO904336L (no) Fremgangsmaate for fremstilling av piperazinoner for anvendelse som svoveldioksyd-absorberende midler.
KR950700896A (ko) 신규의 심장 보호제(Novel Cardioprotective Agents)
IE811612L (en) Thiazoles

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee